Literature DB >> 24092483

Constrained Candecomp/Parafac via the Lasso.

Paolo Giordani1, Roberto Rocci.   

Abstract

The Candecomp/Parafac (CP) model is a well-known tool for summarizing a three-way array by extracting a limited number of components. Unfortunately, in some cases, the model suffers from the so-called degeneracy, that is a solution with diverging and uninterpretable components. To avoid degeneracy, orthogonality constraints are usually applied to one of the component matrices. This solves the problem only from a technical point of view because the existence of orthogonal components underlying the data is not guaranteed. For this purpose, we consider some variants of the CP model where the orthogonality constraints are relaxed either by constraining only a pair, or a subset, of components or by stimulating the CP solution to be possibly orthogonal. We theoretically clarify that only the latter approach, based on the least absolute shrinkage and selection operator and named the CP-Lasso, is helpful in solving the degeneracy problem. The results of the application of CP-Lasso on simulated and real life data show its effectiveness.

Mesh:

Year:  2013        PMID: 24092483     DOI: 10.1007/s11336-013-9321-9

Source DB:  PubMed          Journal:  Psychometrika        ISSN: 0033-3123            Impact factor:   2.500


  3 in total

1.  Sufficient conditions for uniqueness in Candecomp/Parafac and Indscal with random component matrices.

Authors:  Alwin Stegeman; Jos M F Ten Berge; Lieven De Lathauwer
Journal:  Psychometrika       Date:  2017-02-11       Impact factor: 2.500

2.  Degeneracy in Candecomp/Parafac and Indscal Explained For Several Three-Sliced Arrays With A Two-Valued Typical Rank.

Authors:  Alwin Stegeman
Journal:  Psychometrika       Date:  2007-07-28       Impact factor: 2.500

3.  On the Non-Existence of Optimal Solutions and the Occurrence of "Degeneracy" in the CANDECOMP/PARAFAC Model.

Authors:  Wim P Krijnen; Theo K Dijkstra; Alwin Stegeman
Journal:  Psychometrika       Date:  2008-01-29       Impact factor: 2.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.